The HDFN Journey: Living
Find out what’s new and what’s next in treatment options for HDFN.
-
-
Close monitoring key as maternal RBC alloantibody titers rise
-
Small study shows RhD incompatibility may carry low risk of HDFN
-
Study highlights urgent need for better treatments for fetal anemia
-
Infant jaundice cases increase while severe outcomes decrease
-
Study: HDFN still carries great risk for fetuses and infants
-
Rare Patient Voice rewards patients & caregivers for sharing insights
